中国药物应用与监测
中國藥物應用與鑑測
중국약물응용여감측
CHINESE JOURNAL OF DRUG APPLICATION AND MONITORING
2015年
3期
163-166,167
,共5页
朱曼%凡超%郭代红%赵粟裕%马亮%陈超%徐元杰%赵鹏芝%赵靓
硃曼%凡超%郭代紅%趙粟裕%馬亮%陳超%徐元傑%趙鵬芝%趙靚
주만%범초%곽대홍%조속유%마량%진초%서원걸%조붕지%조정
抗感染药物%严重药品不良反应%药品不良事件
抗感染藥物%嚴重藥品不良反應%藥品不良事件
항감염약물%엄중약품불량반응%약품불량사건
Anti-infective agents%Serious adverse drug reaction%Adverse drug events
目的:了解抗感染药物严重药品不良反应/事件(ADR/ADE)的发生规律及特点,为临床用药提供参考。方法:回顾性收集2009–2013年军队ADR监测管理系统中抗感染药物严重ADR/ADE 1175例,对患者性别、年龄、药品种类、给药途径、剂型、累及系统/器官及临床表现、关联性评价及转归等进行描述性分析。结果:1175例患者中,男女比例为1.58:1,平均年龄(49.62±24.57)岁,给药途径以静脉滴注为主,药物类别中喹诺酮类195例(16.60%)、头孢菌素类184例(15.66%)、β-内酰胺酶抑制剂及其复方制剂159例(13.53%)位居前3位。涉及124个单品种,位居前3位的分别为左氧氟沙星73例(6.21%),莫西沙星64例(5.45%),利奈唑胺59例(5.02%)。1175例ADR/ADE中最多见为全身性损害286例次(19.13%),其次为肝胆系统损害203例次(13.58%),皮肤及其附件损害186例次(12.44%)位居第3位;严重ADR表现中位居前3位的分别是肝功能异常162例次(10.84%)、过敏性休克137例次(9.16%)和血小板减少97例次(6.49%)。结论:抗感染药物所致的严重ADR/ADE涉及多个药物类别、品种,累及多个系统/器官,应用时除关注抗感染疗效外,还应监测患者肝肾、血液系统相关指标,以及时处置用药安全问题。
目的:瞭解抗感染藥物嚴重藥品不良反應/事件(ADR/ADE)的髮生規律及特點,為臨床用藥提供參攷。方法:迴顧性收集2009–2013年軍隊ADR鑑測管理繫統中抗感染藥物嚴重ADR/ADE 1175例,對患者性彆、年齡、藥品種類、給藥途徑、劑型、纍及繫統/器官及臨床錶現、關聯性評價及轉歸等進行描述性分析。結果:1175例患者中,男女比例為1.58:1,平均年齡(49.62±24.57)歲,給藥途徑以靜脈滴註為主,藥物類彆中喹諾酮類195例(16.60%)、頭孢菌素類184例(15.66%)、β-內酰胺酶抑製劑及其複方製劑159例(13.53%)位居前3位。涉及124箇單品種,位居前3位的分彆為左氧氟沙星73例(6.21%),莫西沙星64例(5.45%),利奈唑胺59例(5.02%)。1175例ADR/ADE中最多見為全身性損害286例次(19.13%),其次為肝膽繫統損害203例次(13.58%),皮膚及其附件損害186例次(12.44%)位居第3位;嚴重ADR錶現中位居前3位的分彆是肝功能異常162例次(10.84%)、過敏性休剋137例次(9.16%)和血小闆減少97例次(6.49%)。結論:抗感染藥物所緻的嚴重ADR/ADE涉及多箇藥物類彆、品種,纍及多箇繫統/器官,應用時除關註抗感染療效外,還應鑑測患者肝腎、血液繫統相關指標,以及時處置用藥安全問題。
목적:료해항감염약물엄중약품불량반응/사건(ADR/ADE)적발생규률급특점,위림상용약제공삼고。방법:회고성수집2009–2013년군대ADR감측관리계통중항감염약물엄중ADR/ADE 1175례,대환자성별、년령、약품충류、급약도경、제형、루급계통/기관급림상표현、관련성평개급전귀등진행묘술성분석。결과:1175례환자중,남녀비례위1.58:1,평균년령(49.62±24.57)세,급약도경이정맥적주위주,약물유별중규낙동류195례(16.60%)、두포균소류184례(15.66%)、β-내선알매억제제급기복방제제159례(13.53%)위거전3위。섭급124개단품충,위거전3위적분별위좌양불사성73례(6.21%),막서사성64례(5.45%),리내서알59례(5.02%)。1175례ADR/ADE중최다견위전신성손해286례차(19.13%),기차위간담계통손해203례차(13.58%),피부급기부건손해186례차(12.44%)위거제3위;엄중ADR표현중위거전3위적분별시간공능이상162례차(10.84%)、과민성휴극137례차(9.16%)화혈소판감소97례차(6.49%)。결론:항감염약물소치적엄중ADR/ADE섭급다개약물유별、품충,루급다개계통/기관,응용시제관주항감염료효외,환응감측환자간신、혈액계통상관지표,이급시처치용약안전문제。
Objective:To investigate the characteristics of serious adverse drug reaction and events (ADR/ADE) related to anti-infective agents, and provide references for the clinical rational drug use.Methods:A total of 1175 serious ADR/ADE of anti-infective agents were collected from the database of PLA ADR monitoring center from 2009 to 2013. The data in respect of age and gender of patients, categories of suspected anti-infective drugs, route of administration, dosage form, systems and organs involved and clinical manifestations, relevance evaluation and prognosis were analyzed retrospectively.Results:The male to female ratio was 1.58 : 1, the average age of the patients was (49.62 ± 24.57) years, and the main route of administration was intravenous drip. Among suspected drugs, quinolones (195 cases, 16.60%), cephalosporins (184 cases, 15.66%),β-lactamase inhibitor and its compound preparations (159 cases, 13.53%) ranked the top three positions in terms of ADR/ADE frequency. The ADR/ADE were related to 124 kinds of anti-infective agents, levolfoxacin related reports were 73 cases (6.21%), followed by moxilfoxacin (64 cases, 5.45%) and linezolid (59 cases, 5.02%). The 1175 cases of serious ADR/ADE mainly involved systemic damage (286 cases, 19.13%), followed by hepatobiliary system damage (203 cases, 13.58%) and the skin and its appendages damage (186 cases, 12.44%). Abnormal liver function (162 cases, 10.84%) ranked the first place in appearance of serious ADR/ADE, followed by allergic shock (137 cases, 9.16%) and thrombocytopenia (97 cases, 6.49%). Conclusion:Anti-infective drugs associated serious ADR/ADE involved various categories and multiple systems and organs. Besides the efifcacy of anti-infection, we should focus on the function of liver, kidney and hematological system so as to handle safety issues in time.